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Gamma-Interferon Induces Adhesion Molecule Expression in Skin 
The Iymphokjnes a f C the two-edged swords of the immune system. 
They are needed for the initiation and mai.ntenance of normal im-
mune responses, but they can also contribute to tbe development of 
inflanunatory diseases. In chis issue. Jonathan Barker. Michael 
Allen, and Donald MacDonaJd of Guy's Hospital in London, 
England, describe one way in which the lymphokinc gamma-inter-
feron may contribute to inflammatory skin conditions. T he re-
searchers have found tbat it induces rhe expression of the adhesion 
molecules that mediate many responses of the lymphocytes of the 
immune system. 
The current study diH'ers from past work in that the London 
workers examined gamma-interFeron'S effects in the skin of living 
human beings ... A lor of studies have been done oveuhe last 4 years 
looking at the effects of gamma-interferon in vi tro, and the resul ts 
extrapolated to what was going on in vivo in inflammatory dis-
eases" Barker says, "We looked at the in vivo effects." 
To do this, Barker and his colleagues injected gamma-interferon 
daily for 3 days into the skin of 14 volunteers. On the siuh day, they 
took skin biopsies and stained them with monoclonal antibodies for 
LFA-l (lymphocyte function associated antigen 1) and ICAM-l 
(intercellular adhesion molecule 1). The imeraction berween 
LFA-1 on lymphocytes and lCAM-l on other cells helps to trigger 
lymphocyte activation. 
The researchers found that gamma~interferon is a potent inducer 
of ICAM-l expression on both kerarinocytes and endothelial cells 
in {he skin. " In normal skin you don't see ICAM-l on kerarino-
eytes," Barker points out. In addition, the Iymphokine induced 
LFA-l expression by lymphocytes. Comparable changes in adhe-
sion molecule expression had been found in the in vitro studies, but 
the in vivo work also showed that the changes had physiologic 
consequences. may acting to draw lymphocytes into the skin. 
"There was a lymphocyte-ricb infiluate predominantly in rwo 
places- around the endothel ial cdls and basal keratinocytes ex-
pressing the ICAM-l;' Barker says. 
The gamma-interferon also srimulated the expression of LFA-t 
on epidermal Langetharu cells. the antigen-presenting cells of the 
skin , which also participate in lymphocyte activation. "Gamma-in-
terferon, when injected into the skin, can produce many of the 
changes you see i.n inflammatory skin disease, suggesting that it is an 
important cytok..ine in these diseases," Barker explains. 
The findings may have clinical implications. It may be possible to 
design drugs that inhibit gamma-interferon's stimulation of the 
adhesion molecule expression or prevent the molecules fI::om inter-
acting with one another, therehy interfering with the inflammatory 
changes induced by rhe Iymphokine. 
Evidence Found for New Antigen-Presenting Cells in the Dermis 
A great deal of evidence points to the epidermal Langcrhans cells as 
the primary amigcn-presenting cells of the skin. As such they playa 
critical role in the triggering of contact hypersensitiv ity reactions. 
Bur new evidence, described in this issue by J. Wayne 5treilein of 
the University of Miami School of Medicine, indicates thar the 
Langcrhans cell is not the omy skin cell that can present antigens 
and elicit contact hypersensitivity, reactions. Some other, as yet un-
identi6ed, cell located in the dermis also has this ability. "The 
experiment reveals that in certain circumstances yon can bypass the 
Langerhans cells, It Streilein says. 
The 6nd_ing caIne as a big surprise. Streilein was following up on 
earlier experiments showing that contact hypersensitivity is sup-
pressed in some strains of mice that have been treated with low-dose 
UVB. hut not in others. This difference could not be explained by a 
differential effect of the radiation on the skin's Langerhans cells. 
They were severely depleted in all the irradiated animals. Streilein 
hyporhesiz.ed that the resistant suains might have a second, UVB-
insensitive pathway of antigen presentation that is lacking in the 
susceptible animals. 
The current experiments attempted to see if that was the case. 
Streilein used cellophane tape to stri p tbe epidermis and upper 
dermis from the skin of both susceptible and resistant animals. 
thereby removing the animals' Langerhans cells. If his hypothesis 
was correct. then the skin-stripping should have had the same effect 
as UVB irradiation on the susceptible ar.imals. T hey should not 
have been able to develop a contact hypersensitivity reaction. 
Unexpectedly. however, all the animals developed Contact hy-
persensitivity responses. "There must be more than one way to 
induce contact hypersensitivity:' Stteilein says. " In the absolute 
absence of Langerhans cells, then.' must be another cell in the 
dermis-not the epidermis- that can present antigen:' T he der-
mal antigen-presenting cell has not yet been ide.nti6ed, however. 
The new 6ndings necessitate a re~evaluatin of the hypothesis that 
the ability of UVB radiation to suppress contact hypersensitivity in 
some mouse strains is mediated by its effects on epidermal Langer-
hans cells in those animals, As mentioned previously, the radiation 
affects the cells just as severely in the resistam animals as in the 
susceptible ones, and both groups of animals have the new Langer-
hans cell-independent pathway for triggering contact hypersensi-
tivity. It may therefore be necessary to look elsewhere fot an expla-
nation of the effects of UVB on contact hypersensitivity, Streilein 
says. Althongh his experimencs failed to answer his original 
question, they have opened an unexpected new line of inquiry to 
pursue. 
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New Light Shed on the Therapeutic Effects of the Retinoids 
Two papers in rh is issue explore rhe therapeutic actions of rhe reri-
noids. One. from researchers ar rhe University of Michigan School 
of Medicine in Ann Arbor. may help to explain the apparently 
paradoxical actions of the agents on skin cell proliferation - they 
may inhibit keratinocyte growth in some circumstance, but stimu-
late it in others. The second paper. from a grollp at the Hopital 
Henri-Mondor in Crete i! , France. looks at another aspect of reti-
noid actioo. namely. the drugs' immune effects. which may conrrib-
ute to their efficacy in treating inflammatory skin conditions, in-
duding psoriasis. 
Most resc:ucbers have found that all-trans retinoid inhibit., the 
growrh of cultured kerarinocyres, says James Varani of rhe Michi-
gan group. This result is consistenr with rhe therapeutic efficacy of 
the rctinoids in psoriasis, which is characterized by higher than 
normal keratinocyre growth. But it is hard ro reconcile wi th the 
rerinoids.' effects on photoaged skin where the retinoids reduce hne 
wrinkles, apparenrly by stimulating the groY.r[h of the skin cel ls. 
Varani and his Michigan colleagues. Brian Nickoloff, Vishva 
Dixit, Raj Mitra, and John Voorhees, have now found that the 
growth effects of all-tr:ms retinoic acid on culrured keratinocytes 
vary. depending on tbe initial proliferative state of the ceBs. "We 
looked at all-trans rctinoie acid under the conditions other people 
have used. when the cells ate rapidly prol iferating." Vararu says. 
"Under these condi tions, it indeed inhibits proliferation." 
However, when the Michigan workers removed the growth fac-
tors from the medium wed for cu.lturing the keratinocytes, they 
obtained a differenr result. "The cells cease proliferating and go into 
a quasi-differentiated state. These cells are stimulated by che [ecinoie 
acid." Vararu explains. 
The findings may explain the retinoids' discordant effects in vivo, 
the Michigan workers suggest. The proliferative action of the drugs 
in photoaged skin occurs, Vacani notes, nor in the basal cell layer 
where the celts are normally dividing. but in the layer above where 
growth has ceased. These cells m.ight therefore proliferate in re-
sponse to retinoid treatment. In conrrast, the dividing ke.ratinocytes 
of psoriatic skin might respond with slowed cell division. 3S the 
cultured cells do. 
Vauni and his colleagues also found that the all-trans retinoid 
decreases the production by kcratinocytes of thrombospondin and 
fibronectin, adhesion proreins that belp to hold skin and other ce lls 
together. Reduced production of these proteins may contribute to 
the increased fragility seen in the skin of psoriasis patients undergo-
ing treatment with the retinoids. 
Not only do the [etinoids alter keratinocyte growth, but rhey also 
have a number of effects on immune responses. Some of these may 
contribute to the usefulness of the drugs in treating psoriasis. which 
is characterized by an inflammatory in.filtrate as well as by enhanced 
kcratinocyte growth, and other inflammatory conditions sudl as 
lichen planus. But just as with the keratinocyte growth situation, 
the rctinojds have both stimulatory and inhibitory immune effects, 
a sltu:ltion that complicates effons to understand how they improve 
inflammarory skin diseases. 
The group from the Hopital Henri-Mondor. which includes Pat-
rick Dupuy, Martine Bagor, Michele Heslan, and Louis Duhcrtret, 
now reports, however, rhat several synthetic [erinoids inhibit the 
ability of epidermal cells to stimulate rhe growth of lymphocytes 
when rhe two cell-types are grown together in culture. The reri· 
ooids also decreased the cell-kliling abilities of the lymphocytes. 
Since lymphocyte activity contributes to inflammatory responses, 
these inhibitory effecrs of the rerinoids may help ro explain the 
drugs' benefi cial action tn inflammatory skin disease, the re-
searchers suggest. 
The rcrinoids may decrease lymphocyte proliferation by sup-
pressing antigen presentation by the epidermal cells, ;m essential 
step in lymphocyte activation. The French workers see the inhibi-
tory effects of the rcrinoids only when they expose the epidermal 
cells to the drugs before the cells are mixed with the target lympho-
cytes. This suggests that the retinoids act through the epidermal 
cells, although Dupuy and his colleagues have nor yet identified the 
specific way in which rhe drugs affect epidermal cell function . 
